Log In
BCIQ
Print this Print this
 

Lantus, insulin glargine

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionSynthetic sustained-release subcutaneous insulin analog
Molecular Target Insulin receptor (INSR)
Mechanism of ActionInsulin receptor agonist
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentMarketed
Standard IndicationDiabetes
Indication DetailsTreat diabetes; Treat hyperglycemia in Type II diabetics undergoing general surgery; Treat Type I and Type II diabetes; Treat Type I diabetes; Treat Type II diabetes; Treat Type II diabetes mellitus
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
Get a free BioCentury trial today